产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 5mg | 99% | 现货 | |||
| 10mg | 99% | 现货 | |||
| 25mg | 99% | 现货 | |||
| 50mg | 99% | 现货 | |||
| 100mg | 99% | 现货 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 5mg | 99% | 现货 | |||
| 10mg | 99% | 现货 | |||
| 25mg | 99% | 现货 | |||
| 50mg | 99% | 现货 | |||
| 100mg | 99% | 现货 |
CAS No. |
143201-11-0 |
|---|---|
中文名称 |
(3R,5S,E)-7-(4-(4-氟苯基)-2,6-二异丙基-5-(甲氧基甲基)吡啶-3-基)-3,5-二羟基庚-6-烯酸钠盐 |
英文名称 |
(3R,5S,E)-7-(4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)pyridin-3-yl)-3,5-dihydroxyhept-6-enoic acid, sodium salt |
别名 |
bayw6228 | Bay-w-6228 | Tox21_112244_1 | Baycol (TN) | Sodium (3R,5S,6E)-7-(4-(4-fluorophenyl)-2,6-diisopropyl-5-methoxymethyl-3-piridyl)-3,5-dihydroxy-6-heptenoate | Cerivastatin sodium (JAN/USAN) | GPUADMRJQVPIAS-QCVDVZFFSA-M | CERIVASTATIN SODIUM SALT |
标准英文名 |
(3R,5S,E)-7-(4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)pyridin-3-yl)-3,5-dihydroxyhept-6-enoic acid, sodium salt |
分子式 |
C26H34FNO5.Na |
分子量 |
482.23 |
精确分子量 |
482.23 |
SMILES |
OC(C[C@H](O)C[C@H](O)/C=C/C1=C(C(C)C)N=C(C(C)C)C(COC)=C1C2=CC=C(C=C2)F)=O.[Na] |
标准SMILES |
[Na].CC(C)C1N=C(C(C)C)C(COC)=C(C=1/C=C/[C@@H](O)C[C@@H](O)CC(O)=O)C1C=CC(F)=CC=1 |
性状 |
Powder or crystals |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
UVXVKMCFVDNBCD-QCVDVZFFSA-N |
危险类别(旧) |
H302,H315,H319 |
存储要求 |
Inert atmosphere, 2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|